BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase In Subsidiary Holding
AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co.
AnPac Bio Successfully Completes Major PreClinical Study, Files with National Medical Products Administration for Registration Testing of Its Multi-Cancer CDA Device
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ:ANPC), a biotechnology company with operations in the United States and China, today announces that the
AnPac Bio-Medical Services Granted U.S. Patent Titled ‘Micro-devices for disease detection’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11085923.PN.&OS=PN/11085923&RS=PN/11085923
AnPac Bio and Roche Pharmaceuticals China Entered into Cooperation to Explore Innovative Healthcare and Medical Solutions
AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ:ANPC), a biotechnology company with operations in China and the United States, today announced that
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 19)
AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2
AnPac Bio-Medical Science Co Ltd (NASDAQ:ANPC) has announced strong growth in test volume in 1H of 2021. The total number…